
Journal of Pharmaceutical Sciences p. 1013 - 1015 (1979)
Update date:2022-08-03
Topics:
Pettit
Smith
A fragment condensation method was utilized for synthesis of the Trp8-substituted luteinizing hormone-releasing hormone (LHRH). tert-Butoxycarbonyl protection was employed for the α-amino positions, and benzyl protection was used for the phenol group of Tyr and the imidazole nitrogen of His. Peptide bond-forming reactions were performed using N-hydroxysuccinimide (for Trp), dicyclohexylcarbodiimide-1-hydroxybenzotriazole, 1-ethyl-3-(3'-dimethylaminopropyl)-carbodiimide hydrochloride, or mixed carbonic anhydride methods. Biological evaluation of [Trp8]-LH-RH indicated no luteinizing hormone-releasing activity or inhibition of luteinizing hormone release over the dose ranges studied.
Contact:+86-515-88356562
Address:No.2, West Daqing Road, Yancheng, Jiangsu, China
website:http://www.china-sinoway.com
Contact:+86-592-5853819
Address:16/F,Huicheng Comm,Complex,No839 XiaHe Rd, Xiamen,China
Daicel Chiral Technologies (China)CO.,LTD
Contact:021-5046-0086*8
Address:Part C, FL 5, the 16th Building, No. 69, XiYa Road, WaiGaoQiao Free Trade Zone, Shanghai, 200131, P.R.China
Nanjing Samwon International Limited
Contact:+86-25-84873444
Address:1108, BLDG B, New Century Plaza, No 1, South Taiping Rd.,
KangZhiYuan Pharmaceutical Company Limited
Contact:(Sabrina)86-20-85273232
Address:4th floor, building B, Dadi industry zone, Tangxia, Tianhe, Guangzhou, China
Doi:10.1021/jf60143a024
(1966)Doi:10.1246/cl.1979.955
(1979)Doi:10.1021/jo3015209
(2012)Doi:10.1021/jo01275a002
(1968)Doi:10.1039/b102059p
(2001)Doi:10.1021/acs.joc.9b00924
(2019)